Lin, H.; Shen, J.; Zhu, Y.; Zhou, L.; Wu, F.; Liu, Z.; Zhang, S.; Zhan, R.
Elevated Serum CCL23 Levels at Admission Predict Delayed Cerebral Ischemia and Functional Outcome after Aneurysmal Subarachnoid Hemorrhage. J. Clin. Med. 2022, 11, 6879.
https://doi.org/10.3390/jcm11236879
AMA Style
Lin H, Shen J, Zhu Y, Zhou L, Wu F, Liu Z, Zhang S, Zhan R.
Elevated Serum CCL23 Levels at Admission Predict Delayed Cerebral Ischemia and Functional Outcome after Aneurysmal Subarachnoid Hemorrhage. Journal of Clinical Medicine. 2022; 11(23):6879.
https://doi.org/10.3390/jcm11236879
Chicago/Turabian Style
Lin, Hongwei, Jie Shen, Yu Zhu, Lihui Zhou, Fan Wu, Zongchi Liu, Shengxiang Zhang, and Renya Zhan.
2022. "Elevated Serum CCL23 Levels at Admission Predict Delayed Cerebral Ischemia and Functional Outcome after Aneurysmal Subarachnoid Hemorrhage" Journal of Clinical Medicine 11, no. 23: 6879.
https://doi.org/10.3390/jcm11236879
APA Style
Lin, H., Shen, J., Zhu, Y., Zhou, L., Wu, F., Liu, Z., Zhang, S., & Zhan, R.
(2022). Elevated Serum CCL23 Levels at Admission Predict Delayed Cerebral Ischemia and Functional Outcome after Aneurysmal Subarachnoid Hemorrhage. Journal of Clinical Medicine, 11(23), 6879.
https://doi.org/10.3390/jcm11236879